Novartis gets USFDA nod for its therapy to treat Berger’s disease – Healthcare News
Novartis on Thursday announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia (atrasentan) to treat...
News
Akums launches combination formulation for glaucoma and ocular hypertension treatment – Healthcare News
Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment. Glaucoma...
Cell and gene therapy market set to grow at 44% CAGR through 2030, reveals GlobalData – Healthcare News
The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of...
From facility to home: A prescription for change – Healthcare News
By Vikram Thaploo Healthcare has long been criticised for its impersonal and cumbersome nature. Patients frequently encounter a process that...
Immuneel Therapeutics launches global CAR T-cell therapy for Non-Hodgkin’s Lymphoma in India – Healthcare News
Immuneel Therapeutics on Monday launched Qartemi, a CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). According to the company’s...
Newron and Myung In Pharm announce license agreement for schizophrenia therapy in South Korea – Healthcare News
Newron Pharmaceuticals S.p.A. and Myung In Pharm Co. Ltd. on Friday announced that they have entered into a license agreement...
Novartis gene therapy poised to expand SMA treatment landscape – Healthcare News
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in...
AI therapists vs traditional therapy: Can technology redefine mental health care? | Life-style News
Anjana P V, 26, a professional accustomed to traditional therapy, was intrigued when invited to test the emerging world of...
European Commission gives nod to Novartis’ novel therapy to treat breast cancer – Healthcare News
Novartis on Wednesday announced that the European Commission (EC) has approved Kisqali (ribociclib) for the treatment of early breast cancer...
